Validation and implementation of rapid testing for SARS-CoV-2 in the primary care setting
- Conditions
- Coronavirus Disease 1910047438
- Registration Number
- NL-OMON49821
- Lead Sponsor
- HADOKS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 1500
Inclusion Criteria
All patients 18 years and older who visit the corona urgent primary care
facility of the HADOKS (location Haga, Leyweg, The Hague) or the SHR/DDDB
(location Alrijne, Leiderdorp).
Exclusion Criteria
Children younger than 18 years of age.
Insufficient understanding of the Dutch language.
Recent (< 12 hours) intake of alcohol.
Administration of remdesivir and/or dexamethasone before study procedures.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Sensitivity, specificity, positive and negative predictive values of the Abbott<br /><br>PanBio antigen test in relation to the RT-PCR (reference test).</p><br>
- Secondary Outcome Measures
Name Time Method <p>Not applicable</p><br>